Pregled bibliografske jedinice broj: 923824
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis // International journal of hematology, 107 (2018), 2; 166-172 doi:10.1007/s12185-017-2348-4 (podatak o recenziji nije dostupan, članak, znanstveni)
CROSBI ID: 923824 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis
Autori
Lucijanić, Marko ; Mitrović, Zdravko ; Čičić, David ; Prka, Željko ; Pejša, Vlatko ; Livun, Ana ; Štoos‑Veić, Tajana ; Romić, Željko ; Živković, Marcela ; Lucijanić, Iva ; Fabris, Zrinka ; Kušec, Rajko
Izvornik
International journal of hematology (0925-5710) 107
(2018), 2;
166-172
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Philadelphia chromosome negative myeloproliferative neoplasm ; Primary myelofibrosis ; Mean platelet volume ; Survival
Sažetak
Neoplastic megakaryopoiesis is a dominant feature of Philadelphia-chromosome-negative myeloproliferative neoplasms (Ph− MPNs), and elevated mean-platelet-volume (MPV) is a common finding in these diseases. The clinical and prognostic significances of MPV in patients with primary (PMF) and secondary myelofibrosis (SMF) have not been reported. We retrospectively analyzed 87 patients with myelofibrosis (66 with PMF, 21 with SMF) treated at our institution. MPV was recorded in addition to other hematological and clinical parameters. MPV was elevated in both PMF and SMF patients in comparison to controls, whereas there was no statistically significant difference between PMF and SMF. Elevated MPV was associated with lower platelets (P = 0.016), higher white blood cells (P = 0.015), higher percentage of circulatory blasts (P = 0.009), higher lactate dehydrogenase (P = 0.011), larger spleen size (P = 0.014) and higher Dynamic International Prognostic score category (P = 0.027), while there was no statistically significant association with driver mutations or degree of bone marrow fibrosis. Higher MPV was univariately associated with inferior overall survival in the whole cohort (HR = 3.82, P = 0.006), PMF (HR = 4.35, P = 0.007) and SMF patients (HR = 7.22, P = 0.034). These associations remained significant in multivariate analyses adjusted for DIPSS. Higher MPV is associated with more aggressive disease features and exhibits powerful independent prognostic properties in both PMF and SMF settings.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Medicinski fakultet, Osijek,
Opća bolnica Dubrovnik
Profili:
Rajko Kušec
(autor)
Željko Prka
(autor)
Tajana Štoos-Veić
(autor)
Vlatko Pejša
(autor)
Ana Livun
(autor)
Željko Romić
(autor)
Marcela Živković
(autor)
Marko Lucijanic
(autor)
Zdravko Mitrović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- BIOSIS Previews (Biological Abstracts)
- CA Search (Chemical Abstracts)
- CAB Abstracts
- EMBASE (Excerpta Medica)
- CNKI
- EBSCO
- Google Scholar
- Journal Citation Reports/Science Edition
- Gale
- Gale Academic OneFile
- Global Healt
- OCLC WorldCat Discovery Service
- PASCAL
- Pathway Studio
- ProQuest
- Reaxys